Jennifer Van Eyk, Ph.D.
Erika Glazer Chair in Women's Heart Health, Director of Advanced Clinical Biosystems Institute in the Department of Biomedical Sciences, Director of Basic Science Research in the Women's Heart Center, Professor in Medicine and in Biomedical Sciences at Ce
Jennifer Van Eyk, Ph.D. is an international leader in the area of clinical proteomics and her lab has focused on developing technical pipelines for de novo discovery and larger scale quantitative mass spectrometry methods. This includes multiple reaction monitoring (MRM, also known as SRM) and most recently data independent acquisition. Dr. Van Eyk's laboratory is well known for the extreme technical quality of the data generated, rigorous quality control with tight %CV while applying these to key clinical questions. The aim is to maximize throughput and reproducibility in order to move targeted and robust discovery methods into large population healthy continuous assessment and clinical grade assays focusing on brain and cardiovascular diseases.